Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—There is evidence to suggest that low concentrations of testosterone are associated with an increased risk of cardiovascular disease in men. The aim of this study was to evaluate the relationship between serum testosterone concentration and carotid atherosclerosis as well as major cardiovascular risk factors in men with type 2 diabetes. RESEARCH DESIGN AND METHODS—Serum free and total testosterone concentrations were measured in 253 consecutive men with type 2 diabetes. The relationships between serum testosterone concentration and carotid atherosclerosis, determined by ultrasonographically evaluated intima-media thickness (IMT) and plaque score (PS) in a subgroup of 154 diabetic patients, as well as major cardiovascular risk factors, including age, blood pressure, and lipid concentrations, were evaluated. RESULTS—Inverse correlations were found between free testosterone (F-tes) concentration and IMT (r = −0.206, P = 0.0103) and between F-tes concentration and PS (r = −0.334, P < 0.001). The IMT and PS were significantly greater in patients with lower concentrations of F-tes (<10 pg/ml) than in patients with higher concentrations of F-tes (1.01 ± 0.29 vs. 0.91 ± 0.26 mm, P = 0.038; 4.5 ± 3.8 vs. 2.4 ± 3.2, P = 0.0003; respectively). An inverse correlation was found between serum F-tes concentration and age (r = −0.420, P < 0.0001). A positive correlation was found between serum F-tes and total cholesterol concentrations (r = 0.145, P = 0.0238). CONCLUSIONS—Serum F-tes concentration is inversely associated with carotid atherosclerosis determined by ultrasonographically evaluated IMT and PS in men with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Seidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D., & Collins, P. (1999) · Circulation · doi:10.1161/01.cir.100.16.1690 · Cited by 451 · cited 1×
“Testosterone has also been shown to act as a vasodilator in both the coronary and systemic circulations in in vitro animal models (27), and short-term intracoronary administration of testosterone, at physiologic concentrations, induces coronary artery dilation and increases coronary blood flow in men with established…”
BackgroundBrodsky, I. G., Balagopal, P., & Nair, K. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855787 · Cited by 444 · cited 1×
“In contrast, low concentrations of testosterone might lead to increased concentrations of cholesterol by changing body fat distribution (29).”
BackgroundLipids, risk factors and ischaemic heart disease
Castelli, W. P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05851-0 · Cited by 337
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
Testosterone concentrations in women and men with NIDDM
Andersson, B., Märin, P., Lissner, L., Vermeulen, A., & Björntorp, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.405 · Cited by 268 · cited 1×
“Men with diabetes have significantly lower concentrations of free and T-tes than nondiabetic men (10,11).”
BackgroundHaffner, S. M., Valdez, R. A., Mykkänen, L., Stern, M. P., & Katz, M. S. (1994) · Metabolism · doi:10.1016/0026-0495(94)90202-x · Cited by 226
Cited by
Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K. S., & Jones, T. H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0321 · Cited by 389
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 368
Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men
Muller, M., van den Beld, A. W., Bots, M. L., Grobbee, D. E., Lamberts, S. W. J., & van der Schouw, Y. T. (2004) · Circulation · doi:10.1161/01.cir.0000125854.51637.06 · Cited by 321
Testosterone: a vascular hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0582 · Cited by 293
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Metadata
- Authors
- Fukui, M., Kitagawa, Y., Nakamura, N., Kadono, M., Mogami, S., Hirata, C., Ichio, N., Wada, K., Hasegawa, G., & Yoshikawa, T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-06-01
- Volume
- 26
- Issue
- 6
- Pages
- 1869-1873
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2075047759
- Cited by
- 114
- References
- 13
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/diacare.26.6.1869
- The paper
- Fukui, M., Kitagawa, Y., Nakamura, N., Kadono, M., Mogami, S., Hirata, C., Ichio, N., Wada, K., Hasegawa, G., & Yoshikawa, T. (2003). Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.26.6.1869
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.